RT | From Ferguson, Missouri to the deserts of Afghanistan the specter of US aggression is fueling the flames of civil strife and military conflict around an increasingly volatile planet. Much of the problem may be connected to the breakdown of the American psyche.
Before attempting to shed some light on America’s mental condition, let’s open with a pop quiz question: What is the top-selling prescription drug in the US? Nope, it’s not Viagra, not Prozac, forget the Percocet. If you don't know, take a peek in the medicine cabinet because there’s a high chance it’s lurking in there, right behind that purple people eater. Yes, you got it. The top-selling drug in the Land of the Free and Disturbed is an antipsychotic, happily named Abilify.
Once again: The top-selling drug in America is an antipsychotic. Now some might say that’s mental.
“To be a top seller, a drug has to be expensive and also widely used,”
Steven Reidbord M.D. wrote in Psychology Today. “Abilify is both. It’s
the 14th most prescribed brand-name medication, and it retails for
about $30 a pill. Annual sales are over $7 billion, nearly a billion
more than the next runner-up.”
Let those numbers seep into your brain for a moment: $7.2 billion dollars. $30 per pill. Although that might make for some laugh-out-loud late-night comedy, these numbers are no laughing matter.
This on top of the latest statistic that shows prescription drug spending in the US exploded in 2014 to nearly $374 billion, a whopping 13.1 percent increase in growth, according to a new report from IMS Institute for Healthcare Informatics.
Aside from the fact that Americans are buying antipsychotic medication by the truckload, there’s another disturbing thing about Abilify: Nobody, not even the Food and Drug Administration (FDA), has any idea what makes it effective. According to the USPI label that accompanies each bottle: “The mechanism of action of aripiprazole... is unknown. However, the efficacy of aripiprazole could be mediated through a combination of partial agonist activity at D2 and 5-HT1A receptors and… etc, etc.”
In other words, millions of Americans are ingesting an antipsychotic drug that not even the scientific community can say exactly what makes it work. Is that not in itself the very definition of insanity?
So where is the uproar, the protest, the media hype over this battle for the great American brain? Behind the wall of silence, there have been a few courageous experts who have broken rank with their colleagues - not to mention the omnipotent pharmaceutical industry - to blow the whistle on the abuse of psychiatric drugs in America.
Let those numbers seep into your brain for a moment: $7.2 billion dollars. $30 per pill. Although that might make for some laugh-out-loud late-night comedy, these numbers are no laughing matter.
This on top of the latest statistic that shows prescription drug spending in the US exploded in 2014 to nearly $374 billion, a whopping 13.1 percent increase in growth, according to a new report from IMS Institute for Healthcare Informatics.
Aside from the fact that Americans are buying antipsychotic medication by the truckload, there’s another disturbing thing about Abilify: Nobody, not even the Food and Drug Administration (FDA), has any idea what makes it effective. According to the USPI label that accompanies each bottle: “The mechanism of action of aripiprazole... is unknown. However, the efficacy of aripiprazole could be mediated through a combination of partial agonist activity at D2 and 5-HT1A receptors and… etc, etc.”
In other words, millions of Americans are ingesting an antipsychotic drug that not even the scientific community can say exactly what makes it work. Is that not in itself the very definition of insanity?
So where is the uproar, the protest, the media hype over this battle for the great American brain? Behind the wall of silence, there have been a few courageous experts who have broken rank with their colleagues - not to mention the omnipotent pharmaceutical industry - to blow the whistle on the abuse of psychiatric drugs in America.
0 comments:
Post a Comment